<DOC>
	<DOC>NCT02921568</DOC>
	<brief_summary>This study is designed to evaluate and compare in-tissue performance of OCT scans on the new Optos P200TE, versus the predicate Optos Spectral OCT/SLO device.</brief_summary>
	<brief_title>Side-by-Side Comparison of P200TE and Spectral OCT/SLO on Diseased Eyes</brief_title>
	<detailed_description />
	<mesh_term>Retinal Diseases</mesh_term>
	<criteria>1. Male or female subjects 18 years of age or older who have full legal capacity to volunteer; 2. Subjects who have signed the informed consent; 3. Subjects who can follow the instructions by the clinical staff at the clinical site, and can attend examinations on the scheduled examination date; 4. Subjects who agree to participate in the study; 5. Subjects with current BSCVA 20/400 or better in the ocular disease study eye(s); 6. Subjects diagnosed with ocular disease including but not limited to: Macular Degeneration, Diabetic Macular Edema, Diabetic Retinopathy, Central Serous Retinopathy, Macular Hole, Epiretinal Membrane, Macular Edema, Glaucoma, and others in the retinal disease study eye(s) as confirmed at the study visit or within the past six (6) months. 1. Subjects unable to tolerate ophthalmic imaging; 2. Subjects with ocular media not sufficiently clear to obtain acceptable OCT images; 3. Subjects without ocular disease in study eye(s), as determined by selfreport and/or investigator assessment at the study visit; 4. Subjects with history of leukemia, dementia or multiple sclerosis.</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2016</verification_date>
</DOC>